Ignite Creation Date:
2025-12-24 @ 4:43 PM
Ignite Modification Date:
2025-12-28 @ 1:11 AM
Study NCT ID:
NCT00389766
Status:
WITHDRAWN
Last Update Posted:
2013-07-10
First Post:
2006-10-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
High-Dose Iodine I 131 Metaiodobenzylguanidine, Topotecan, and Peripheral Stem Cell Transplant in Treating Young Patients With Relapsed Stage 4 Neuroblastoma or Primary Resistant High-Risk Neuroblastoma
Sponsor:
Children's Cancer and Leukaemia Group
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-07
Start Date Type:
None
Primary Completion Date:
2008-07
Primary Completion Date Type:
ESTIMATED
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2006-10-18
First Submit QC Date:
None
Study First Post Date:
2006-10-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-07-09
Last Update Post Date:
2013-07-10
Last Update Post Date Type:
ESTIMATED